JP2024527401A5 - - Google Patents
Info
- Publication number
- JP2024527401A5 JP2024527401A5 JP2024501831A JP2024501831A JP2024527401A5 JP 2024527401 A5 JP2024527401 A5 JP 2024527401A5 JP 2024501831 A JP2024501831 A JP 2024501831A JP 2024501831 A JP2024501831 A JP 2024501831A JP 2024527401 A5 JP2024527401 A5 JP 2024527401A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- composition according
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163221261P | 2021-07-13 | 2021-07-13 | |
| US63/221,261 | 2021-07-13 | ||
| PCT/CN2022/105077 WO2023284710A1 (en) | 2021-07-13 | 2022-07-12 | Methods of treating neurological diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527401A JP2024527401A (ja) | 2024-07-24 |
| JP2024527401A5 true JP2024527401A5 (https=) | 2025-07-22 |
Family
ID=84919904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501831A Pending JP2024527401A (ja) | 2021-07-13 | 2022-07-12 | 神経学的疾患を処置する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240309089A1 (https=) |
| EP (1) | EP4370153A4 (https=) |
| JP (1) | JP2024527401A (https=) |
| KR (1) | KR20240042443A (https=) |
| CN (1) | CN117999096A (https=) |
| AU (1) | AU2022310081A1 (https=) |
| CA (1) | CA3225077A1 (https=) |
| MX (1) | MX2024000591A (https=) |
| WO (1) | WO2023284710A1 (https=) |
| ZA (1) | ZA202400405B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3710471A1 (en) * | 2017-11-16 | 2020-09-23 | Kite Pharma, Inc. | Modified chimeric antigen receptors and methods of use |
| WO2024197258A1 (en) * | 2023-03-23 | 2024-09-26 | Klaritos, Inc | Methods of treating alzheimer's disease |
| WO2025190311A1 (en) * | 2024-03-12 | 2025-09-18 | Sinomab Bioscience Limited | Method of identifying anti-siglec antibodies possessing cis-trans converter properties, anti-siglec antibodies and use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201203442D0 (en) * | 2012-02-28 | 2012-04-11 | Univ Birmingham | Immunotherapeutic molecules and uses |
| US9066928B1 (en) * | 2012-12-04 | 2015-06-30 | University Of Kentucky Research Foundation | Method, composition, and kit useful for treatment of alzheimer's disease |
| AU2014305658A1 (en) * | 2013-08-05 | 2016-02-11 | St. Vincent's Institute Of Medical Research | An antibody therapy for amyloid beta disease |
| WO2017196432A1 (en) * | 2016-05-12 | 2017-11-16 | La Jolla Institute For Allergy And Immunology | Compositions and methods for diagnosing and treating neurodegenerative disease |
| EP3867280A4 (en) * | 2018-10-18 | 2022-11-09 | Sinomab Bioscience Limited | METHODS OF TREATMENT OF RHEUMATOID ARTHRITIS |
| ES2821599A1 (es) * | 2019-10-24 | 2021-04-26 | Univ Del Pais Vasco / Euskal Herriko Unibertsitatea | Compuestos y metodos para el tratamiento de la enfermedad de alzheimer |
-
2022
- 2022-07-12 MX MX2024000591A patent/MX2024000591A/es unknown
- 2022-07-12 US US18/578,300 patent/US20240309089A1/en active Pending
- 2022-07-12 CA CA3225077A patent/CA3225077A1/en active Pending
- 2022-07-12 EP EP22841346.4A patent/EP4370153A4/en active Pending
- 2022-07-12 KR KR1020247004608A patent/KR20240042443A/ko active Pending
- 2022-07-12 WO PCT/CN2022/105077 patent/WO2023284710A1/en not_active Ceased
- 2022-07-12 JP JP2024501831A patent/JP2024527401A/ja active Pending
- 2022-07-12 AU AU2022310081A patent/AU2022310081A1/en active Pending
- 2022-07-12 CN CN202280061890.XA patent/CN117999096A/zh active Pending
-
2024
- 2024-01-11 ZA ZA2024/00405A patent/ZA202400405B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024527401A5 (https=) | ||
| KR102757960B1 (ko) | 간세포암(hepatocellular carcinoma: HCC)에 대한 면역 치료 | |
| TWI306458B (en) | Humanized antibodies that recognize beta amyloid peptide | |
| JP2021191763A5 (https=) | ||
| JP2006522830A5 (https=) | ||
| JP2018502558A5 (https=) | ||
| JP2019527194A5 (https=) | ||
| CA2478049A1 (en) | Humanized antibodies that recognize beta amyloid peptide | |
| JP2023541860A5 (https=) | ||
| CA2494008A1 (en) | Anti-myelin associated glycoprotein (mag) antibodies | |
| JP2019505527A5 (https=) | ||
| JP2009530423A5 (https=) | ||
| JP2023542290A5 (https=) | ||
| JP2013508292A5 (https=) | ||
| JP2021511387A5 (https=) | ||
| JP2021525806A5 (https=) | ||
| JP2019517540A5 (https=) | ||
| JP2020527152A5 (https=) | ||
| JP2023516441A5 (https=) | ||
| JP2023548064A5 (https=) | ||
| JP2022542472A5 (https=) | ||
| JP2022500382A5 (https=) | ||
| JP2023546504A5 (https=) | ||
| JP2025130076A5 (https=) | ||
| US20240417451A1 (en) | Therapeutic Use of Bispecific Anti-Abeta/TfR Antibodies |